Overview

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Status:
Completed
Trial end date:
1992-12-01
Target enrollment:
0
Participant gender:
All
Summary
To determine whether electrophysiologic study (EPS) or Holter monitoring (HM) was the better method for selecting effective long-term antiarrhythmic drug therapy in patients with sustained ventricular tachycardia, ventricular fibrillation, or an episode of aborted sudden death.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Utah
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Imipramine
Mexiletine
Procainamide
Quinidine
Sotalol
Criteria
Men and women with documented ventricular tachycardia and those resuscitated from sudden
death.